Curaleaf (OTCMKTS:CURLF) Shares Up 12.2% – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) rose 12.2% during trading on Thursday . The stock traded as high as $3.56 and last traded at $3.5450. Approximately 1,475,284 shares traded hands during mid-day trading, an increase of 36% from the average daily volume of 1,084,176 shares. The stock had previously closed at $3.16.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Strong Buy”.

Curaleaf Stock Down 1.5%

The firm has a market capitalization of $2.45 billion, a PE ratio of -26.96 and a beta of 1.58. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The company has a 50-day moving average price of $2.97 and a 200 day moving average price of $2.68.

Shares of Curaleaf are set to reverse split on the morning of Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, June 4th.

Curaleaf (OTCMKTS:CURLF) last issued its earnings results on Tuesday, May 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.17. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The company had revenue of $324.23 million for the quarter, compared to the consensus estimate of $316.62 million. Analysts forecast that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.